查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594434

无针糖尿病护理市场：按设备类型、最终用户划分 - 2025-2030 年全球预测

Needle Free Diabetes Care Market by Device Type (Insulin Infuser, Insulin Patches, Insulin Pens), End User (Consumer, Diagnostic Center, Hospitals & Clinic) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

无针糖尿病护理市场2023年估值为138.7亿美元，预计到2024年将达到161.1亿美元，复合年增长率为16.26%，预计到2030年将达到398.3亿美元。

无针糖尿病护理市场范围包括针对传统无针糖尿病管理的设备和技术，例如连续血糖监测（CGM）系统、胰岛素帮浦和喷射注射器。这些技术的需求源自于传统针刺方法带来的不适和不便，旨在提高患者的依从性和生活品质。这些技术主要由医院、诊所和家庭护理等最终用户应用，用于监测血糖值和管理胰岛素。糖尿病盛行率不断上升、对非侵入性监测设备的需求不断增加、医疗保健技术的进步以及患者意识的提高对市场产生了重大影响。研发投资的激增和主要企业之间的策略联盟代表了促进创新和提供差异化产品的潜在商机。糖尿病人口不断增加、医疗基础设施不断发展的新兴市场也代表着开拓的商机。然而，市场面临无针器材高成本、法规要求严格、新兴市场意识缺乏等挑战。此外，技术限制和可靠资料的准确性可能会阻碍采用率。为了推动成长并克服这些挑战，公司正在利用基于奈米技术的输送系统、用于持续监控的智慧穿戴设备以及用于个人化医疗保健解决方案的物联网和糖尿病护理设备整合等技术。市场充满活力且竞争激烈，技术进步不断改变格局。公司可以透过投资于用户友好的设计、确保负担能力以及提高产品的准确性和效率来提高竞争力。此外，我们对以患者为中心的方法的关注以及与医疗保健提供者的合作将有助于推动无针糖尿病护理领域的广泛采用和市场扩张。

主要市场统计
基准年[2023] 138.7亿美元
预测年份 [2024] 161.1亿美元
预测年份 [2030] 398.3亿美元
复合年增长率（%） 16.26%

市场动态：快速发展的无针糖尿病护理市场的关键市场洞察

无针糖尿病护理市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 糖尿病和肥胖人口增加
    • 用于疾病管理的智慧型手机应用程式的增加
    • 提高对糖尿病及其治疗的认识
  • 市场限制因素
    • 对与该设施相关的高成本和技术错误的担忧
  • 市场机会
    • 糖尿病治疗技术的进步
    • 扩大无针糖尿病治疗的采用
  • 市场挑战
    • 穿刺和针刺伤感染的风险很高

波特五力：驾驭无针糖尿病照护市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解无针糖尿病护理市场的外部影响

外部宏观环境因素在塑造无针糖尿病护理市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解无针糖尿病护理市场的竞争格局

对无针糖尿病护理市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵无针糖尿病护理市场供应商的绩效评估

FPNV定位矩阵是评估无针糖尿病护理市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了无针糖尿病护理市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，无针糖尿病护理市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 糖尿病和肥胖人口增加
      • 用于疾病管理的智慧型手机应用程式的增加
      • 提高对疾病和治疗方法的认识
    • 抑制因素
      • 对与该设施相关的高成本和技术错误的担忧
    • 机会
      • 糖尿病照护的技术进步
      • 无针糖尿病治疗的采用率增加
    • 任务
      • 蜇伤和针刺感染的风险很高
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第 6 章按设备类型分類的无针糖尿病护理市场

  • 胰岛素注射器
  • 胰岛素贴片
  • 胰岛素笔
  • 胰岛素帮浦
  • 喷射注射器

第 7 章 无针糖尿病护理市场：依最终使用者分类

  • 消费者
  • 诊断中心
  • 医院/诊所

第八章北美和南美无针糖尿病护理市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区无针糖尿病照护市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲的无针糖尿病护理市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Akra Dermojet
  • Antares Pharma, Inc.
  • Bioject Medical Technologies Inc.
  • Echo Therapeutics Inc.
  • European Pharma Group BV
  • Injex Pharma AG
  • MannKind Corporation
  • Medical International Technology, Inc.
  • Pharmajet, Inc.
  • The 3M Company
Product Code: MRR-036C5CF3B492

The Needle Free Diabetes Care Market was valued at USD 13.87 billion in 2023, expected to reach USD 16.11 billion in 2024, and is projected to grow at a CAGR of 16.26%, to USD 39.83 billion by 2030.

The scope of the needle-free diabetes care market involves devices and technologies aimed at diabetes management without the use of traditional needles, including continuous glucose monitoring (CGM) systems, insulin pumps, and jet injectors. The necessity of these technologies arises from the discomfort and inconvenience associated with traditional needle-based methods, aiming to enhance patient compliance and quality of life. They are applied in monitoring blood glucose levels and administering insulin, primarily by end-users such as hospitals, clinics, and home care settings. The market is significantly influenced by the increasing prevalence of diabetes, growing demand for non-invasive monitoring devices, advancements in healthcare technologies, and rising patient awareness. A surge in R&D investments and strategic collaborations between key players are potential opportunities, as they promote innovation and offer differentiated products. Emerging markets with a growing diabetic population and evolving healthcare infrastructures also present untapped opportunities. However, the market faces challenges such as the high costs of needle-free devices, stringent regulatory requirements, and a lack of awareness in developing regions. Furthermore, technological limitations and reliable data accuracy can impede adoption rates. To foster growth and overcome these challenges, businesses can focus on innovative areas such as nanotechnology-based delivery systems, smart wearable devices for continuous monitoring, and integrating IoT with diabetes care devices for personalized healthcare solutions. The market is dynamic and competitive, with technological advancements consistently shaping its landscape. Companies can gain a competitive edge by investing in user-friendly designs, ensuring affordability, and enhancing the precision and efficiency of their offerings. The emphasis on patient-centric approaches and collaborations with healthcare providers can also promote widespread adoption and market expansion in the needle-free diabetes care domain.

KEY MARKET STATISTICS
Base Year [2023] USD 13.87 billion
Estimated Year [2024] USD 16.11 billion
Forecast Year [2030] USD 39.83 billion
CAGR (%) 16.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Needle Free Diabetes Care Market

The Needle Free Diabetes Care Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of diabetes and obese population
    • Increasing number of smartphone apps for disease management
    • Rising awareness regarding the disease and the treatments
  • Market Restraints
    • High cost associated with the facility and concerns regarding technical errors
  • Market Opportunities
    • Technological advancements for diabetes care
    • Growing adoption of needle-free diabetes management
  • Market Challenges
    • High risk of infection because of poking and needle-stick injuries

Porter's Five Forces: A Strategic Tool for Navigating the Needle Free Diabetes Care Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Needle Free Diabetes Care Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Needle Free Diabetes Care Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Needle Free Diabetes Care Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Needle Free Diabetes Care Market

A detailed market share analysis in the Needle Free Diabetes Care Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Needle Free Diabetes Care Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Needle Free Diabetes Care Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Needle Free Diabetes Care Market

A strategic analysis of the Needle Free Diabetes Care Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Needle Free Diabetes Care Market, highlighting leading vendors and their innovative profiles. These include Akra Dermojet, Antares Pharma, Inc., Bioject Medical Technologies Inc., Echo Therapeutics Inc., European Pharma Group BV, Injex Pharma AG, MannKind Corporation, Medical International Technology, Inc., Pharmajet, Inc., and The 3M Company.

Market Segmentation & Coverage

This research report categorizes the Needle Free Diabetes Care Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device Type, market is studied across Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, and Jet Injectors.
  • Based on End User, market is studied across Consumer, Diagnostic Center, and Hospitals & Clinic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of diabetes and obese population
      • 5.1.1.2. Increasing number of smartphone apps for disease management
      • 5.1.1.3. Rising awareness regarding the disease and the treatments
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the facility and concerns regarding technical errors
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements for diabetes care
      • 5.1.3.2. Growing adoption of needle-free diabetes management
    • 5.1.4. Challenges
      • 5.1.4.1. High risk of infection because of poking and needle-stick injuries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Needle Free Diabetes Care Market, by Device Type

  • 6.1. Introduction
  • 6.2. Insulin Infuser
  • 6.3. Insulin Patches
  • 6.4. Insulin Pens
  • 6.5. Insulin Pumps
  • 6.6. Jet Injectors

7. Needle Free Diabetes Care Market, by End User

  • 7.1. Introduction
  • 7.2. Consumer
  • 7.3. Diagnostic Center
  • 7.4. Hospitals & Clinic

8. Americas Needle Free Diabetes Care Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Needle Free Diabetes Care Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Needle Free Diabetes Care Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Akra Dermojet
  • 2. Antares Pharma, Inc.
  • 3. Bioject Medical Technologies Inc.
  • 4. Echo Therapeutics Inc.
  • 5. European Pharma Group BV
  • 6. Injex Pharma AG
  • 7. MannKind Corporation
  • 8. Medical International Technology, Inc.
  • 9. Pharmajet, Inc.
  • 10. The 3M Company

LIST OF FIGURES

  • FIGURE 1. NEEDLE FREE DIABETES CARE MARKET RESEARCH PROCESS
  • FIGURE 2. NEEDLE FREE DIABETES CARE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. NEEDLE FREE DIABETES CARE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. NEEDLE FREE DIABETES CARE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEEDLE FREE DIABETES CARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEEDLE FREE DIABETES CARE MARKET DYNAMICS
  • TABLE 7. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN INFUSER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY JET INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY CONSUMER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY DIAGNOSTIC CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY HOSPITALS & CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM NEEDLE FREE DIABETES CARE MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NEEDLE FREE DIABETES CARE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. NEEDLE FREE DIABETES CARE MARKET, FPNV POSITIONING MATRIX, 2023